It looks as though things are progressing faster than anticipated at OKYO Pharma (OKYO), the biotechnology company focused on dry eye diseases and ocular pain.
Poolbeg signs Option Agreement with University College Dublin for a Melioidosis Vaccine candidate, MelioVac, and a licence to evaluate 5 other infectious disease portfolio assets
BrandShield Systems (BRSD), the cybersecurity solutions group, announced new data regarding the rise of e-commerce fraud ahead of another potentially record-breaking Black Friday shopping event, which saw consumers spend over
US infectious diseases expert, Professor Daniel Hoft, joins Scientific Advisory Board 25 November 2021- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical-stage infectious disease pharmaceutical company with a
This week Share Talk presents a live Q&A webinar with Paul Johnson – CEO Power Metal Resources (AIM: POW) 23rd November 2021 at 8 pm (GMT) along with Zak Mir hosting the
We may be due some fresh messaging from Tirupati Graphite (TGR), the specialist graphite producer, as it announced the appointment of FTI Consulting as its retained Public Relations and Financial
Rapidly progressing towards LPS challenge study
Zak Mir takes a technical perspective on some of the most followed stocks on the London market. Today’s selection includes Gunsynd, Gaming Realms, Kavango, Kinovo, Mkango, Open Orphan, Poolbeg, Petroneft,
Bitcoin reached $60,000 on Friday for the first time in six months. This was in line with expectations that U.S. regulators will allow futures-based exchange-traded funds (ETF) which could open
Zak Mir takes a technical perspective on some of the most followed stocks on the London market. Today’s selection includes Castillo, GSTechnology, Hurricane, Landore, Oracle, Powerhouse, Poolbeg, Real Good, Tekcapital,
Clinical stage infectious disease pharmaceutical company Poolbeg Pharma (POLB) updated on new patent filings for its PredictViral™ platform that estimates disease severity and contagiousness in people who are recently infected
